title: Ossiculoplasty with hydroxyapatite bone cement: our reconstruction philosophy.
abstract: The main objective of this study is to analyze results obtained with hydroxyapatite bone cement (HABC) ossiculoplasties. This is a retrospective study of a case series. This study was conducted in an academic hospital and tertiary referral center. A total of 127 ossiculoplasties using HABC were evaluated. Ears were divided into three groups according to procedure: group 1 involved reinforcement of the incudostapedial joint with cement and reconstruction of an incus long process defect with cement. Group 2 involved partial ossicular reconstruction between the stapes and malleus handle with HABC. Group 3 was divided into two subgroups. Group 3B entailed reconstruction of the stapes with a mobile footplate (Austin-Kartush type B = group 3B) and group 3F with a fixed footplate (Austin-Kartush type F = group 3F) using a K-Helix piston (Grace Medical, Memphis, TN, USA) or a classical titanium piston (Kurz, Fuerth, Germany) glued to the incus remnant or malleus handle with cement. Anatomical and pre- and postoperative audiological results were assessed. The mean follow-up was 26 ± 14 months. Percentages of average postoperative air-bone gap ≤ 20 dB were 95, 82.5, 50 and 83.3%, and for air-bone gap ≤ 1 0 dB, 80, 50.9, 16.6 and 50% for groups 1, 2, 3B and 3F, respectively. No complications related to the cement or extrusion occurred. Hearing outcomes also remained stable over time. In our experience, ossiculoplasty with cement provides good and stable functional results, is safe, cost effective, and easy to use. HABC with or without biocompatible ossicular prostheses allows repair of different types of ossicular defects with preservation of the anatomical and physiological ossicular chain, as well as improved stability. Reconstruction of the incus long process or incudostapedial joint defect with cement is preferred over partial ossicular reconstruction.
authors.affiliation: Department of ENT and Head and Neck Surgery, Saint-Luc University Hospital, 1200, Brussels, Belgium, j-m.gerard@uclouvain.be.
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Gérard
authors.forename: Gersende
authors.initials: G
authors.lastname: De Bie
authors.forename: Daniel
authors.initials: D
authors.lastname: Franceschi
authors.forename: Naima
authors.initials: N
authors.lastname: Deggouj
authors.forename: Michel
authors.initials: M
authors.lastname: Gersdorff
mesh_terms: D001530:Belgium; D001843:Bone Cements / Q000627:therapeutic use; D004429:Ear Ossicles / Q000473:pathology / Q000601:surgery*; D005260:Female; D006314:Hearing Loss, Conductive / Q000209:etiology / Q000601:surgery; D006801:Humans; D006882:Hydroxyapatites / Q000627:therapeutic use*; D007759:Labyrinth Diseases / Q000150:complications / Q000601:surgery*; D008297:Male; D011183:Postoperative Complications / Q000175:diagnosis / Q000601:surgery; D011184:Postoperative Period; D019651:Plastic Surgery Procedures / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D012086:Reoperation; D012189:Retrospective Studies; D013201:Stapes Surgery / Q000009:adverse effects / Q000295:instrumentation / Q000379:methods; D016896:Treatment Outcome
chemical_list: D001843:Bone Cements; D006882:Hydroxyapatites; C475044:hydroxyapatite cement